http://dbpedia.org/ontology/abstract
|
Immune Therapy Holdings AB or ITH is a Swe … Immune Therapy Holdings AB or ITH is a Swedish biotechnology R&D holding company headquartered at the Karolinska Institutet and Karolinska University Hospital in Stockholm. ITH's research is primarily focused on its Tailored Leukapheresis (TLA) treatment for immune mediated inflammatory diseases (IMIDs).ne mediated inflammatory diseases (IMIDs).
|
http://dbpedia.org/ontology/foundingYear
|
2005
|
http://dbpedia.org/ontology/industry
|
http://dbpedia.org/resource/Research_and_development +
|
http://dbpedia.org/ontology/keyPerson
|
http://dbpedia.org/resource/Chief_executive_officer +
, http://dbpedia.org/resource/Chief_technology_officer +
, http://dbpedia.org/resource/Hans_Glise +
|
http://dbpedia.org/ontology/location
|
http://dbpedia.org/resource/Sweden +
, http://dbpedia.org/resource/Stockholm +
|
http://dbpedia.org/ontology/product
|
http://dbpedia.org/resource/Immunotherapy +
|
http://dbpedia.org/ontology/thumbnail
|
http://commons.wikimedia.org/wiki/Special:FilePath/Immune_Therapy_Holdings_logo.png?width=300 +
|
http://dbpedia.org/ontology/type
|
http://dbpedia.org/resource/Privately_held_company +
|
http://dbpedia.org/ontology/wikiPageExternalLink
|
https://ithgroup.se/ +
|
http://dbpedia.org/ontology/wikiPageID
|
42277447
|
http://dbpedia.org/ontology/wikiPageLength
|
6507
|
http://dbpedia.org/ontology/wikiPageRevisionID
|
1038958205
|
http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/European_Union +
, http://dbpedia.org/resource/Category:Biotechnology_companies_established_in_2005 +
, http://dbpedia.org/resource/Compound_annual_growth_rate +
, http://dbpedia.org/resource/Aktiebolag +
, http://dbpedia.org/resource/Clinical_trial +
, http://dbpedia.org/resource/White_blood_cells +
, http://dbpedia.org/resource/Rheumatoid_arthritis +
, http://dbpedia.org/resource/Category:Swedish_companies_established_in_2005 +
, http://dbpedia.org/resource/Chemokine +
, http://dbpedia.org/resource/List_of_Swedish_inventions +
, http://dbpedia.org/resource/Swedish_Institute +
, http://dbpedia.org/resource/Multiple_sclerosis +
, http://dbpedia.org/resource/Karolinska_Institutet +
, http://dbpedia.org/resource/Chief_technology_officer +
, http://dbpedia.org/resource/Dagens_Medicin +
, http://dbpedia.org/resource/Clinical_endpoint +
, http://dbpedia.org/resource/VINNOVA +
, http://dbpedia.org/resource/Chemokine_receptor +
, http://dbpedia.org/resource/Karolinska_University_Hospital +
, http://dbpedia.org/resource/Immunotherapy +
, http://dbpedia.org/resource/Swedish_Research_Council +
, http://dbpedia.org/resource/Acute_respiratory_distress_syndrome +
, http://dbpedia.org/resource/Swedish_Krona +
, http://dbpedia.org/resource/Privately_held_company +
, http://dbpedia.org/resource/Eureka_%28organization%29 +
, http://dbpedia.org/resource/Category:Biotechnology +
, http://dbpedia.org/resource/R&D +
, http://dbpedia.org/resource/Immune-mediated_inflammatory_diseases +
, http://dbpedia.org/resource/Chairman +
, http://dbpedia.org/resource/Sweden +
, http://dbpedia.org/resource/Stockholm +
, http://dbpedia.org/resource/Primary_sclerosing_cholangitis +
, http://dbpedia.org/resource/Research_and_development +
, http://dbpedia.org/resource/Placebo-controlled_study +
, http://dbpedia.org/resource/Amyotrophic_lateral_sclerosis +
, http://dbpedia.org/resource/Alcoholic_hepatitis +
, http://dbpedia.org/resource/Extracorporeal +
, http://dbpedia.org/resource/Inflammatory_bowel_disease +
, http://dbpedia.org/resource/Biotechnology +
, http://dbpedia.org/resource/Therapy +
, http://dbpedia.org/resource/Hans_Glise +
, http://dbpedia.org/resource/Category:Research_and_development_in_Sweden +
, http://dbpedia.org/resource/Apheresis +
, http://dbpedia.org/resource/Holding_company +
, http://dbpedia.org/resource/Chief_executive_officer +
|
http://dbpedia.org/property/foundation
|
2005
|
http://dbpedia.org/property/homepage
|
https://ithgroup.se/ +
|
http://dbpedia.org/property/industry
|
http://dbpedia.org/resource/Research_and_development +
|
http://dbpedia.org/property/keyPeople
|
Ahsan Amjad , Ola Winqvist , Hans Glise ,
|
http://dbpedia.org/property/location
|
http://dbpedia.org/resource/Sweden +
, http://dbpedia.org/resource/Stockholm +
|
http://dbpedia.org/property/logo
|
Immune Therapy Holdings logo.png
|
http://dbpedia.org/property/name
|
Immune Therapy Holdings AB
|
http://dbpedia.org/property/products
|
http://dbpedia.org/resource/Immunotherapy +
|
http://dbpedia.org/property/type
|
http://dbpedia.org/resource/Privately_held_company +
, http://dbpedia.org/resource/Aktiebolag +
|
http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Citation_needed +
, http://dbpedia.org/resource/Template:Infobox_company +
, http://dbpedia.org/resource/Template:Reflist +
, http://dbpedia.org/resource/Template:Orphan +
|
http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Research_and_development_in_Sweden +
, http://dbpedia.org/resource/Category:Biotechnology_companies_established_in_2005 +
, http://dbpedia.org/resource/Category:Biotechnology +
, http://dbpedia.org/resource/Category:Swedish_companies_established_in_2005 +
|
http://purl.org/linguistics/gold/hypernym
|
http://dbpedia.org/resource/R +
|
http://www.w3.org/2004/02/skos/core#closeMatch
|
http://www.grid.ac/institutes/grid.451728.d +
|
http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/Immune_Therapy_Holdings?oldid=1038958205&ns=0 +
|
http://xmlns.com/foaf/0.1/depiction
|
http://commons.wikimedia.org/wiki/Special:FilePath/Immune_Therapy_Holdings_logo.png +
|
http://xmlns.com/foaf/0.1/homepage
|
https://ithgroup.se/ +
|
http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/Immune_Therapy_Holdings +
|
http://xmlns.com/foaf/0.1/name
|
Immune Therapy Holdings AB
|
owl:sameAs |
http://rdf.freebase.com/ns/m.0102kdpx +
, http://yago-knowledge.org/resource/Immune_Therapy_Holdings +
, http://dbpedia.org/resource/Immune_Therapy_Holdings +
, https://global.dbpedia.org/id/eYgo +
, http://www.wikidata.org/entity/Q16847440 +
|
rdf:type |
http://dbpedia.org/class/yago/YagoLegalActorGeo +
, http://dbpedia.org/class/yago/YagoLegalActor +
, http://dbpedia.org/class/yago/Company108058098 +
, http://dbpedia.org/ontology/Agent +
, http://dbpedia.org/class/yago/Abstraction100002137 +
, http://www.wikidata.org/entity/Q24229398 +
, http://dbpedia.org/class/yago/SocialGroup107950920 +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#SocialPerson +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#Agent +
, http://dbpedia.org/ontology/Company +
, http://www.wikidata.org/entity/Q4830453 +
, http://dbpedia.org/class/yago/YagoPermanentlyLocatedEntity +
, http://www.wikidata.org/entity/Q43229 +
, http://dbpedia.org/class/yago/Institution108053576 +
, http://schema.org/Organization +
, http://dbpedia.org/ontology/Organisation +
, http://dbpedia.org/class/yago/Group100031264 +
, http://dbpedia.org/class/yago/Organization108008335 +
|
rdfs:comment |
Immune Therapy Holdings AB or ITH is a Swe … Immune Therapy Holdings AB or ITH is a Swedish biotechnology R&D holding company headquartered at the Karolinska Institutet and Karolinska University Hospital in Stockholm. ITH's research is primarily focused on its Tailored Leukapheresis (TLA) treatment for immune mediated inflammatory diseases (IMIDs).ne mediated inflammatory diseases (IMIDs).
|
rdfs:label |
Immune Therapy Holdings
|